Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by 2b7f6fabon Aug 19, 2024 3:16pm
205 Views
Post# 36186512

RE:warrants Aug 22

RE:warrants Aug 22
I tend to agree with your theory about waiting for the warrants to expire this week before any large investors want in.

I believe there is interest in Theralase from large investors.  However considering the small market cap I don't think mgmt wants to lose control of the company.  $5 million investment at 20 cents is 25 million shares.  Much more than insiders have right now.  Anything is possible I guess.  I doubt debt will be involved since no bank gives credit to a company without substantial operating revenues/profit.  One possiblity would be a combination of shares and royalty stream on the revenues of ruvidar.  A one percent royalty should easily be worth north of $5 million.

glta
<< Previous
Bullboard Posts
Next >>